healthexecwire



  Click here to view this message in a web browser
 
 
Implications of the COVID-19 Pandemic on Medical Loss Ratio for Health Plans
Wednesday, December 2, 2020 | 1:00PM - 2:00PM Eastern

 
  • Review of Medical Loss Ratio formula, requirements and current issues
  • COVID-19 initial MLR impact
  • Market-specific considerations for Commercial, Medicare Advantage and Medicaid
  • COVID-19 future implications and considerations

Faculty:
Jennifer Carioto, FSA, MAAA, Consulting Actuary, Milliman
Andrew Bochner, FSA, MAAA, Consulting Actuary, Milliman
Luis O. Maldonado Irizarry, FSA, MAAA, Consulting Actuary, Milliman
 
 

Register Now
 
The COVID-19 pandemic will have a significant impact in all segments of healthcare for a prolonged period. As such, health plans have critical financial decisions to make in the upcoming months with limited data available and wide uncertainty on how the COVID-19 pandemic will transition toward the end of 2020 and into 2021.

How will COVID-19 affect a health plan’s medical loss ratio requirements in general and what are specific considerations for the commercial, Medicare Advantage, and Medicaid markets in 2020 and going forward?

This session explores how COVID-19 may impact a health plan’s medical loss ratio (MLR) requirements in general and provides specific considerations for the Commercial, Medicare Advantage and Medicaid markets at the end of 2020 and into the future.
Click here for more details.

 

Please join us on Wednesday, December 2nd, at 1 PM Eastern as Milliman’s Jennifer Carioto, Andrew Bochner, and Luis O. Maldonado Irizarry, discuss the initial and longer-range impact of COVID-19 on health plan MLR including market-specific considerations for Commercial, MA and Medicaid. Click here for detailed information or to register or call 209.577.4888.
 
 

  

healthexecwire
www.healthexecwire.com